Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Advanced Brain and Spine Tumor Treatments using Radiosurgery Technology

By HospiMedica International staff writers
Posted on 17 Sep 2008
Unlike conventional surgery, new radiosurgery technology is completely noninvasive and does not require a surgical incision. More...
This eliminates the discomfort and complications associated with standard surgery.

Integra LifeSciences Holdings Corp. (Plainsboro, NJ, USA) reported that clinicians using the Radionics XKnife presented their latest developments in the treatment of brain and spine tumors on July 27, 2008, at the 50th annual meeting of the American Association of Physicists, held in Medicine in Houston, TX, USA. The Radionics XKnife radiosurgery system was developed, manufactured, and marketed by Integra LifeSciences Holdings Corp., through its Integra NeuroSciences team.

Dr. Satish Jaywant, associate professor of radiation oncology at Robert Wood Johnson University Hospital (New Brunswick, NJ, USA), presented his latest research using Radionics XKnife and ImageFusion software and cone beam computed tomography (CT) to achieve stereotactic accuracy for extracranial targets.

Dr. Nilendu Gupta, associate professor and chief of clinical medical physics at James Cancer Center at the Ohio State Medical Center (Columbus, OH, USA), also presented his research in commissioning the XKnife system for stereotactic spine treatments. Dr. Emilie Soisson, medical physicist and assistant researcher at the University of Wisconsin Hospital and Clinics, presented her work on the Radionics InterFix system for intracranial stereotactic positioning for use on the TomoTherapy Hi-Art system.

"It's exciting to see the advances our customers are making to treat tumors throughout the body utilizing the Radionics XKnife system as well as the Radionics InterFix radiosurgery kit,” said Jason D. Ellnor, director of marketing for stereotaxy at Integra NeuroSciences.

With this technology, cancerous or other diseased tissue can be treated with focused radiation beams from a linear accelerator (linac) that are precisely guided using CT, magnetic resonance imaging (MRI), and positron emission tomography (PET) images. Neighboring normal tissue is spared and patients are typically able to leave the hospital immediately after their treatment. To date, over 45,000 patients have undergone Radionics XKnife radiosurgery.

The Radionics InterFix radiosurgery kit provides a way to adapt the existing Integra NeuroSciences stereotactic hardware to the TomoTherapy Hi-Art system for stereotactic treatment of cranial tumors and vascular malformations.

TomoTherapy, Inc. (Madison, WI, USA) develops, manufactures, and sells the TomoTherapy Hi-Art treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The Hi-Art treatment system combines integrated CT imaging with helical intensity modulated radiation therapy to provide advanced treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue.

Integra LifeSciences develops systems to improving the quality of life for patients through the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. The company's products are used to treat millions of patients every year, primarily in neurosurgery, extremity reconstruction, orthopedics, and general surgery.

Related Links:
Integra LifeSciences
Robert Wood Johnson University Hospital
Ohio State Medical Center
TomoTherapy


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.